0.1952
price down icon5.79%   -0.012
 
loading
전일 마감가:
$0.2072
열려 있는:
$0.2069
하루 거래량:
4.22M
Relative Volume:
0.24
시가총액:
$6.97M
수익:
-
순이익/손실:
$-18.35M
주가수익비율:
-0.1683
EPS:
-1.16
순현금흐름:
$-19.20M
1주 성능:
-9.12%
1개월 성능:
-5.61%
6개월 성능:
-58.11%
1년 성능:
-86.35%
1일 변동 폭
Value
$0.195
$0.212
1주일 범위
Value
$0.1926
$0.2224
52주 변동 폭
Value
$0.1651
$1.75

Theriva Biologics Inc Stock (TOVX) Company Profile

Name
명칭
Theriva Biologics Inc
Name
전화
301 417 4364
Name
주소
9605 Medical Center Drive, Suite 270, Rockville
Name
직원
21
Name
트위터
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
TOVX's Discussions on Twitter

TOVX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
TOVX
Theriva Biologics Inc
0.1952 7.39M 0 -18.35M -19.20M -1.16
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.36 111.36B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
733.04 77.98B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
800.01 50.33B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
359.27 47.46B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ONC
Beone Medicines Ltd Adr
338.19 37.43B 4.98B 69.59M 525.67M 0.5197

Theriva Biologics Inc 주식(TOVX)의 최신 뉴스

pulisher
Jan 16, 2026

Is Theriva Biologics Inc backed by strong institutional buyingJuly 2025 Outlook & Technical Entry and Exit Tips - baoquankhu1.vn

Jan 16, 2026
pulisher
Jan 15, 2026

Theriva Biologics (NYSEAMERICAN:TOVX) Stock Price Down 4.9% – Time to Sell? - Defense World

Jan 15, 2026
pulisher
Jan 14, 2026

Dow Update: Can Theriva Biologics Inc continue delivering strong returnsWeekly Trade Report & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn

Jan 14, 2026
pulisher
Jan 13, 2026

Can Theriva Biologics Inc continue delivering strong returnsQuarterly Portfolio Summary & Long-Term Growth Plans - baoquankhu1.vn

Jan 13, 2026
pulisher
Jan 12, 2026

Theriva Biologics advances VCN-01 toward Phase 3 trial - TipRanks

Jan 12, 2026
pulisher
Jan 10, 2026

How Theriva Biologics Inc. stock performs in rate cut cyclesProfit Target & Consistent Growth Equity Picks - Улправда

Jan 10, 2026
pulisher
Jan 09, 2026

How Theriva Biologics Inc. stock reacts to fiscal policiesPortfolio Return Summary & AI Forecasted Entry/Exit Points - Улправда

Jan 09, 2026
pulisher
Jan 08, 2026

Will Theriva Biologics Inc. stock profit from fiscal stimulusJuly 2025 Institutional & Free Technical Pattern Based Buy Signals - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Can Theriva Biologics Inc. stock maintain operating margins2025 Trading Recap & Technical Analysis for Trade Confirmation - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Is Theriva Biologics Inc. stock undervalued vs historical averagesOil Prices & Risk Managed Investment Entry Signals - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Can Theriva Biologics Inc. stock deliver sustainable ROE2025 Technical Overview & Comprehensive Market Scan Insights - ulpravda.ru

Jan 08, 2026
pulisher
Jan 06, 2026

Will Theriva Biologics Inc. stock benefit from green energy trends2026 world cup usa national team semifinals defensive leaders pressing system match prediction preview - ulpravda.ru

Jan 06, 2026
pulisher
Jan 06, 2026

Why Theriva Biologics Inc. stock is favored by pension funds2026 world cup usa national team quarterfinals goalkeepers low block defense match prediction statistical analysis - Улправда

Jan 06, 2026
pulisher
Jan 06, 2026

How Theriva Biologics Inc. stock benefits from strong dollar2026 world cup usa national team group stage playmakers possession football winner prediction insights - Улправда

Jan 06, 2026
pulisher
Jan 03, 2026

Theriva Biologics Incto Schedule End-of-Ph - 富途牛牛

Jan 03, 2026
pulisher
Jan 01, 2026

Sentiment Watch: Is Theriva Biologics Inc stock at risk of policy regulationJuly 2025 EndofMonth & Long Hold Capital Preservation Plans - Bộ Nội Vụ

Jan 01, 2026
pulisher
Dec 31, 2025

Theriva Biologics receives EMA approval for VCN-01 Phase 3 trial - Intellectia AI

Dec 31, 2025
pulisher
Dec 30, 2025

Theriva Biologics receives CHMP scientific advice on VCN-01 Phase 3 design - Yahoo Finance

Dec 30, 2025
pulisher
Dec 30, 2025

Theriva Biologics stock soars after EMA backs Phase 3 trial design - Investing.com Australia

Dec 30, 2025
pulisher
Dec 30, 2025

Theriva Biologics gains EMA backing for VCN-01 phase 3 - MSN

Dec 30, 2025
pulisher
Dec 30, 2025

Theriva receives EMA guidance for pancreatic cancer drug trial design By Investing.com - Investing.com Nigeria

Dec 30, 2025
pulisher
Dec 29, 2025

Why Is Theriva Biologics Stock Gaining Monday? - Benzinga

Dec 29, 2025
pulisher
Dec 29, 2025

Theriva Biologics (TOVX) Prepares for Phase 3 Trial with EMA Gui - GuruFocus

Dec 29, 2025
pulisher
Dec 29, 2025

Theriva Biologics Announces EMA Advice on Phase 3 Trial for VCN-01 - TradingView — Track All Markets

Dec 29, 2025
pulisher
Dec 29, 2025

Theriva Biologics (TOVX) outlines EMA CHMP advice on VCN-01 Phase 3 trial in metastatic pancreatic cancer - Stock Titan

Dec 29, 2025
pulisher
Dec 29, 2025

Theriva™ Biologics Announces Positive Scientific Advice - GlobeNewswire

Dec 29, 2025
pulisher
Dec 27, 2025

Guidance Update: What market sentiment indicators show for Theriva Biologics Inc. (SFY0) stock2025 Macro Impact & Growth Focused Entry Point Reports - Bộ Nội Vụ

Dec 27, 2025
pulisher
Dec 24, 2025

Theriva Biologics (NYSEAMERICAN:TOVX) Trading 5.2% Higher – Here’s Why - Defense World

Dec 24, 2025
pulisher
Dec 23, 2025

What drives Theriva Biologics Inc stock priceDebt-to-Equity Ratio Analysis & Free Expert Stock Watchlists - earlytimes.in

Dec 23, 2025
pulisher
Dec 23, 2025

Theriva Biologics (TOVX) asks holders to OK 16.18M warrant shares, $8.7M cash - Stock Titan

Dec 23, 2025
pulisher
Dec 23, 2025

Have you been able to find a good deal on Theriva Biologics Inc’s shares? - uspostnews.com

Dec 23, 2025
pulisher
Dec 20, 2025

Highs Report: Why institutional investors increase stakes in Theriva Biologics Inc. (SFY0) stock2025 Market Sentiment & Safe Swing Trade Setup Alerts - moha.gov.vn

Dec 20, 2025
pulisher
Dec 20, 2025

Why Theriva Biologics Inc. stock appeals to dividend investorsJuly 2025 Spike Watch & Free Weekly Chart Analysis and Trade Guides - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Hedge Fund Moves: Is Theriva Biologics Inc. stock supported by strong fundamentals2025 Market Overview & Precise Entry and Exit Recommendations - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

Is Theriva Biologics Inc. stock supported by strong fundamentals - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

How risky is Theriva Biologics Inc. stock nowFed Meeting & Free Accurate Trade Setup Notifications - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Can Theriva Biologics Inc. stock deliver strong Q4 earningsJuly 2025 Technicals & Daily Oversold Stock Bounce Ideas - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Is Theriva Biologics Inc. stock at risk of policy regulationJuly 2025 Reactions & Weekly Watchlist for Hot Stocks - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

What analyst consensus implies for Theriva Biologics Inc. (SFY0) stockJuly 2025 Catalysts & Short-Term Swing Trade Alerts - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Is Theriva Biologics Inc. stock a fit for income portfoliosJuly 2025 Fed Impact & High Return Stock Watch Alerts - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Can Theriva Biologics Inc. stock sustain free cash flow growthWeekly Trade Review & Community Verified Swing Trade Signals - Улправда

Dec 19, 2025
pulisher
Dec 18, 2025

Will Theriva Biologics Inc. (SFY0) stock draw ESG focused funds2025 Sector Review & Free Expert Approved Momentum Trade Ideas - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Why analysts recommend Theriva Biologics Inc. stock2025 EndofYear Setup & Fast Gain Stock Trading Tips - Улправда

Dec 18, 2025
pulisher
Dec 15, 2025

Theriva Biologics to reschedule special stockholder meeting after lack of quorum - Investing.com Nigeria

Dec 15, 2025
pulisher
Dec 15, 2025

Theriva Biologics Reschedules Special Stockholder Meeting - TipRanks

Dec 15, 2025
pulisher
Dec 15, 2025

Theriva Biologics reschedules special stockholder meeting - MSN

Dec 15, 2025
pulisher
Dec 15, 2025

Theriva Biologics (NYSE American: TOVX) to hold new vote on warrant share issuance - Stock Titan

Dec 15, 2025
pulisher
Dec 12, 2025

US Market Recap: How Theriva Biologics Inc SFY0 stock reacts to stronger dollarQuarterly Growth Report & Fast Moving Trade Plans - moha.gov.vn

Dec 12, 2025
pulisher
Dec 11, 2025

Earnings Risk: How Theriva Biologics Inc SFY0 stock responds to job market shiftsCPI Data & AI Powered Market Trend Analysis - moha.gov.vn

Dec 11, 2025
pulisher
Dec 05, 2025

Why Theriva Biologics Inc. stock is a strong buy call2025 Analyst Calls & AI Driven Stock Reports - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Can Theriva Biologics Inc. (SFY0) stock test all time highs2025 Market Overview & Verified Swing Trading Watchlists - Newser

Dec 05, 2025

Theriva Biologics Inc (TOVX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$32.25
price down icon 4.73%
$106.21
price up icon 0.92%
$120.28
price down icon 2.43%
$109.00
price up icon 2.76%
$161.42
price up icon 1.35%
biotechnology ONC
$338.19
price down icon 0.03%
자본화:     |  볼륨(24시간):